J&J Covid-19 vaccine trial moves into late stage

Washington (AFP) – Johnson & Johnson said Wednesday it was entering the final Phase 3 stage of its Covid-19 vaccine clinical trial following positive results in earlier stages.The trial will seek to enroll up to 60,000 volunteers across more than 200 sites in the US and around the world, the company and the US National Institutes for Health (NIH), which is providing funding, said.With the move, J&J becomes the tenth maker globally to conduct a Phase 3 trial against Covid-19, and the fourth in the US.The company, which is developing the vaccine on a not-for-profit basis through its subsidiary J…

Read More

HEDGE accordingly